Zetia vs Repatha: Cost, Access, and Clinical Outcomes Head-to-Head
A detailed comparison of ezetimibe (Zetia) and evolocumab (Repatha) covering cost, insurance access, LDL-lowering efficacy, and cardiovascular outcomes from IMPROVE-IT and FOURIER.
Zetia vs Repatha: Side-Effect Profile Head-to-Head
A clinical comparison of ezetimibe (Zetia) and evolocumab (Repatha) side effects, tolerability, discontinuation rates, and safety data from IMPROVE-IT and FOURIER trials.
Zetia vs Repatha: Switching Between Ezetimibe and Evolocumab
Zetia vs Repatha: ezetimibe lowers LDL about 18-25% on top of a statin; Repatha (evolocumab) about 59%. Guidelines say try ezetimibe first, then Repatha.